These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
676 related articles for article (PubMed ID: 33671292)
21. Targeted delivery of doxorubicin using a colorectal cancer-specific ssDNA aptamer. Li W; Chen H; Yu M; Fang J Anat Rec (Hoboken); 2014 Dec; 297(12):2280-8. PubMed ID: 25044297 [TBL] [Abstract][Full Text] [Related]
22. Dual targeting luminescent gold nanoclusters for tumor imaging and deep tissue therapy. Chen D; Li B; Cai S; Wang P; Peng S; Sheng Y; He Y; Gu Y; Chen H Biomaterials; 2016 Sep; 100():1-16. PubMed ID: 27236844 [TBL] [Abstract][Full Text] [Related]
23. Multifunctional DNA-gold nanoparticles for targeted doxorubicin delivery. Alexander CM; Hamner KL; Maye MM; Dabrowiak JC Bioconjug Chem; 2014 Jul; 25(7):1261-71. PubMed ID: 24911830 [TBL] [Abstract][Full Text] [Related]
24. Photothermal therapeutic response of cancer cells to aptamer-gold nanoparticle-hybridized graphene oxide under NIR illumination. Yang L; Tseng YT; Suo G; Chen L; Yu J; Chiu WJ; Huang CC; Lin CH ACS Appl Mater Interfaces; 2015 Mar; 7(9):5097-106. PubMed ID: 25705789 [TBL] [Abstract][Full Text] [Related]
25. The effective nuclear delivery of doxorubicin from dextran-coated gold nanoparticles larger than nuclear pores. Jang H; Ryoo SR; Kostarelos K; Han SW; Min DH Biomaterials; 2013 Apr; 34(13):3503-10. PubMed ID: 23395274 [TBL] [Abstract][Full Text] [Related]
26. Smart drug delivery of p-Coumaric acid loaded aptamer conjugated starch nanoparticles for effective triple-negative breast cancer therapy. Mariadoss AVA; Saravanakumar K; Sathiyaseelan A; Karthikkumar V; Wang MH Int J Biol Macromol; 2022 Jan; 195():22-29. PubMed ID: 34861273 [TBL] [Abstract][Full Text] [Related]
27. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044 [TBL] [Abstract][Full Text] [Related]
28. Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy. Iranpour S; Bahrami AR; Nekooei S; Sh Saljooghi A; Matin MM J Nanobiotechnology; 2021 Oct; 19(1):314. PubMed ID: 34641857 [TBL] [Abstract][Full Text] [Related]
30. Gold nanoparticle-DNA aptamer composites as a universal carrier for in vivo delivery of biologically functional proteins. Ryou SM; Yeom JH; Kang HJ; Won M; Kim JS; Lee B; Seong MJ; Ha NC; Bae J; Lee K J Control Release; 2014 Dec; 196():287-94. PubMed ID: 25450403 [TBL] [Abstract][Full Text] [Related]
31. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance. Liu J; Wei T; Zhao J; Huang Y; Deng H; Kumar A; Wang C; Liang Z; Ma X; Liang XJ Biomaterials; 2016 Jun; 91():44-56. PubMed ID: 26994877 [TBL] [Abstract][Full Text] [Related]
32. Hyperthermia Induced by Gold Nanoparticles and Visible Light Photothermy Combined with Chemotherapy to Tackle Doxorubicin Sensitive and Resistant Colorectal Tumor 3D Spheroids. Roma-Rodrigues C; Pombo I; Fernandes AR; Baptista PV Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126535 [TBL] [Abstract][Full Text] [Related]
33. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles. Ruan S; Yuan M; Zhang L; Hu G; Chen J; Cun X; Zhang Q; Yang Y; He Q; Gao H Biomaterials; 2015 Jan; 37():425-35. PubMed ID: 25453970 [TBL] [Abstract][Full Text] [Related]
34. AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer. Hosseini NF; Amini R; Ramezani M; Saidijam M; Hashemi SM; Najafi R Biomed Pharmacother; 2022 Nov; 155():113690. PubMed ID: 36099793 [TBL] [Abstract][Full Text] [Related]
35. Anti-Proliferative Effect of Doxorubicin-Loaded AS1411 Aptamer on Colorectal Cancer Cell. Lohlamoh W; Soontornworajit B; Rotkrua P Asian Pac J Cancer Prev; 2021 Jul; 22(7):2209-219. PubMed ID: 34319045 [TBL] [Abstract][Full Text] [Related]
36. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777 [TBL] [Abstract][Full Text] [Related]
37. Double targeting, controlled release and reversible delivery of daunorubicin to cancer cells by polyvalent aptamers-modified gold nanoparticles. Taghdisi SM; Danesh NM; Lavaee P; Emrani AS; Hassanabad KY; Ramezani M; Abnous K Mater Sci Eng C Mater Biol Appl; 2016 Apr; 61():753-61. PubMed ID: 26838906 [TBL] [Abstract][Full Text] [Related]
38. A potent multifunctional ZIF-8 nanoplatform developed for colorectal cancer therapy by triple-delivery of chemo/radio/targeted therapy agents. Iranpour S; Bahrami AR; Dayyani M; Saljooghi AS; Matin MM J Mater Chem B; 2024 Jan; 12(4):1096-1114. PubMed ID: 38229578 [TBL] [Abstract][Full Text] [Related]
39. Nanoplatform based on GSH-responsive mesoporous silica nanoparticles for cancer therapy and mitochondrial targeted imaging. He H; Meng S; Li H; Yang Q; Xu Z; Chen X; Sun Z; Jiang B; Li C Mikrochim Acta; 2021 Apr; 188(5):154. PubMed ID: 33821295 [TBL] [Abstract][Full Text] [Related]
40. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer. Bagheri E; Abnous K; Farzad SA; Taghdisi SM; Ramezani M; Alibolandi M Life Sci; 2020 Nov; 261():118369. PubMed ID: 32882265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]